三葉草生物－Ｂ(02197.HK)RSV候選疫苗I期臨床試驗首批受試者完成入組

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

三葉草生物－Ｂ(02197.HK)RSV候選疫苗I期臨床試驗首批受試者完成入組

阿思達克 12-13 08:58

三葉草生物－Ｂ(02197.HK)公布，在評估公司呼吸道合胞病毒(RSV) PreF－三聚體亞單位候選疫苗(SCB-1019)的I期人體臨床試驗中，首批受試者已完成入組。公司指，該候選疫苗是基於公司獨有創新的蛋白質三聚體化(Trimer-Tag)疫苗技術平台開發。

三葉草生物-B(02197.HK)

Relevant Stocks

三葉草生物-B(02197.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

三葉草生物－Ｂ(02197.HK)RSV候選疫苗I期臨床試驗首批受試者完成入組

Services

About Us

Agreement Statement